Literature DB >> 27667895

A semivarying joint model for longitudinal binary and continuous outcomes.

Esra Kürüm1, John Hughes2, Runze Li3.   

Abstract

Semivarying models extend varying coefficient models by allowing some regression coefficients to be constant with respect to the underlying covariate(s). In this paper we develop a semivarying joint modelling framework for estimating the time-varying association between two intensively measured longitudinal response: a continuous one and a binary one. To overcome the major challenge of jointly modelling these responses, namely, the lack of a natural multivariate distribution, we introduce a Gaussian latent variable underlying the binary response. Then we decompose the model into two components: a marginal model for the continuous response, and a conditional model for the binary response given the continuous response. We develop a two-stage estimation procedure and discuss the asymptotic normality of the resulting estimators. We assess the finite-sample performance of our procedure using a simulation study, and we illustrate our method by analyzing binary and continuous responses from the Women's Interagency HIV Study.

Entities:  

Keywords:  Generalized varying coefficient model; HIV; local linear regression; profile least squares

Year:  2015        PMID: 27667895      PMCID: PMC5033063          DOI: 10.1002/cjs.11273

Source DB:  PubMed          Journal:  Can J Stat        ISSN: 0319-5724            Impact factor:   0.875


  17 in total

1.  Latent variable models for longitudinal data with multiple continuous outcomes.

Authors:  J Roy; X Lin
Journal:  Biometrics       Date:  2000-12       Impact factor: 2.571

2.  Analysis of Longitudinal Data with Semiparametric Estimation of Covariance Function.

Authors:  Jianqing Fan; Tao Huang; Runze Li
Journal:  J Am Stat Assoc       Date:  2007-06-01       Impact factor: 5.033

Review 3.  Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals.

Authors:  Raymond Niaura; Geetanjali Chander; Heidi Hutton; Cassandra Stanton
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

4.  Numerical and functional alterations in circulatory lymphocytes in cigarette smokers.

Authors:  D A Hughes; P L Haslam; P J Townsend; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

5.  Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects.

Authors:  M Ferson; A Edwards; A Lind; G W Milton; P Hersey
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

6.  An epidemiologic study of interrelationships of total serum immunoglobulin E, allergy skin-test reactivity, and eosinophilia.

Authors:  M Halonen; R A Barbee; M D Lebowitz; B Burrows
Journal:  J Allergy Clin Immunol       Date:  1982-02       Impact factor: 10.793

7.  The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans.

Authors:  Kristina Crothers; Tephany A Griffith; Kathleen A McGinnis; Maria C Rodriguez-Barradas; David A Leaf; Sharon Weissman; Cynthia L Gibert; Adeel A Butt; Amy C Justice
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

Review 8.  Cigarette smoking and infection.

Authors:  Lidia Arcavi; Neal L Benowitz
Journal:  Arch Intern Med       Date:  2004-11-08

9.  Joint Models for the Association of Longitudinal Binary and Continuous Processes With Application to a Smoking Cessation Trial.

Authors:  Xuefeng Liu; Michael J Daniels; Bess Marcus
Journal:  J Am Stat Assoc       Date:  2009-06-01       Impact factor: 5.033

10.  Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.

Authors:  Christian Obirikorang; Francis A Yeboah
Journal:  J Biomed Sci       Date:  2009-11-18       Impact factor: 8.410

View more
  1 in total

1.  A Bayesian shared parameter model for joint modeling of longitudinal continuous and binary outcomes.

Authors:  T Baghfalaki; M Ganjali; A Kabir; A Pazouki
Journal:  J Appl Stat       Date:  2020-09-18       Impact factor: 1.416

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.